-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on Alnylam Pharmaceuticals, Raises Price Target to $479

Benzinga·11/11/2025 14:25:09
Listen to the news
Wells Fargo analyst Derek Archila maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Equal-Weight and raises the price target from $395 to $479.